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Abstract
Introduction: During severe sepsis or septic shock, activation of the inflammatory and coagulatory systems can
result in microcirculatory dysfunction as well as microvascular thrombosis, culminating in multiple organ
dysfunction and death. Enoxaparin can inhibit factor Xa and attenuate endothelial damage. The primary purpose of
this study was to investigate the effect of enoxaparin on intestinal microcirculation in endotoxemic rats.
Methods: Thirty male Wistar rats were divided into the following three groups: sham operated (OP);
lipopolysaccharide (LPS); and LPS + Enoxaparin group. The rats received a midline laparotomy to exteriorize a
segment of terminal ileum for microcirculation examination by full-field laser perfusion imager and sidestream dark
field video microscope on mucosa, muscle, and Peyer’s patch. In the LPS and LPS + Enoxaparin groups, 15 mg/kg
LPS was administered intravenously to induce endotoxemia, and 400 IU/kg enoxaparin sodium was also
administered in the LPS + Enoxaparin group.
Results: At 240 minutes, the mean arterial pressure was higher in the LPS + Enoxaparin group than in the LPS
group (93 ± 9 versus 64 ± 16 mm Hg, P < 0.001). Microcirculatory blood flow intensity was higher in the LPS +
Enoxaparin group than in the LPS group as follows: mucosa (1085 ± 215 versus 617 ± 214 perfusion unit [PU], P <
0.001); muscle (760 ± 202 versus 416 ± 223 PU, P = 0.001); and Peyer’s patch (1,116 ± 245 versus 570 ± 280 PU,
P < 0.001). Enoxaparin inhibited LPS-induced reduction in perfused small vessel density and increase in
heterogeneity of microcirculation.
Conclusions: Enoxaparin can prevent intestinal microcirculatory dysfunction in endotoxemic rats by preventing
microvascular thrombosis formation and maintaining normal mean arterial pressure.
Introduction
Severe sepsis and septic shock are the leading causes of
multiple organ dysfunction and death in patients
admitted to ICUs. Although the Surviving Sepsis Cam-
paign guidelines led to a decrease in hospital mortality
[1], one-year mortality remains high ranging from 21.5%
to 71.9% [2]. Increasing evidence supports the existence
of an extensive cross-talk between inflammation and
coagulation during sepsis [3], and activation of the
inflammatory and coagulation systems and down regula-
tion of endothelial-bound anticoagulant mechanisms can
cause disseminated microvascular thrombosis [4].
Microvascular thrombosis can prevent oxygen from
reaching tissues, decrease the perfused small vessel den-
sity, and increase the spatial heterogeneity of the per-
fused small vessel [5]. These effects lead to tissue
ischemia, organ hypoperfusion and further, multiple
organ dysfunction and death [6-8].
Early intestinal microcirculatory dysfunction has been
observed even in normotensive sepsis [9] and it may lead
to complications such as altered intestinal motility [10],
mucosa barrier disruption, bacterial translocation [11],
and multiple organ dysfunction syndrome [12]. There-
fore, the intestinal microcirculation provides an excellent
site to investigate sepsis-related microcirculatory dys-
function [13,14]. Many advanced techniques have been
developed to investigate microcirculation. A full-field
laser perfusion imager can be used to quantitatively mea-
sure microcirculatory blood flow intensity [15]. A side-
stream dark-field (SDF) video microscope has been used
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to visualize the small vessel and can calculate the small
vessel density, microvascular flow index, and heterogene-
ity of microcirculation [8].
Enoxaparin sodium is a low-molecular-weight heparin.
Its high-affinity fraction of heparin sulfate inhibits factor
Xa by catalyzing its binding to antithrombin. It can pre-
vent microvascular thrombosis and attenuate endothelial
damage in endotoxemic rats [16]. In the present study,
we hypothesized that enoxaparin can prevent microcircu-
latory dysfunction during severe sepsis and septic shock
by reducing microvascular thrombosis. The primary pur-
pose of this study was to investigate the effect of enoxa-
parin on intestinal microcirculation in endotoxemic rats
by application of the full-field laser perfusion imager and
the SDF video microscope.
Materials and methods
A total of 30 male Wistar rats (body weight 250 ± 50 g;
Biolasco Taiwan Co., Taipei, Taiwan) were used in this
study, which was approved by the Institutional Animal
Care and Use Committee (No. 20110308, College of
Medicine, National Taiwan University, Taipei, Taiwan).
The rats were kept on a 12-hour light/dark cycle and had
free access to water and food.
Anesthesia and surgical procedure
Anesthesia was initiated with 4% isoflurane by using an
induction chamber connected to an animal anesthesia
machine (Midmark Co., Orchard Park, NY, USA). After
the rat was anaesthetized, it was placed supine on an ani-
mal warming pad. The anesthesia was maintained using
2% isoflurane by mask. Subcutaneous 0.05 mg/kg atro-
pine sulfate in 10 ml/kg 0.9% NaCl was given to reduce
respiratory tract secretion, to block vagal reflexes elicited
by manipulation of intestinal viscera, and to replace
water vapor loss. Tracheostomy was performed and a
14-G catheter (Surflo; Terumo Corporation, Laguna,
Philippines) was inserted into the trachea. Subsequent
anesthesia was maintained using 1.2% isoflurane. Poly-
ethylene catheters (PE-50; Intramedic 7411, Clay Adams,
Parsippany, NJ, USA) were inserted into the right com-
mon carotid artery and external jugular vein. The right
common carotid artery catheter was used to continuously
monitor arterial blood pressure and heart rate. A contin-
uous infusion of 8 ml/kg/hr 0.9% NaCl was given as
maintenance fluid supplement via the external jugular
vein catheter. The body temperature was continuously
monitored. A three cm long midline laparotomy was per-
formed to exteriorize a segment of terminal ileum (about
6 to 10 cm proximal to the ileocecal valve). A two cm
section was performed on the anti-mesenteric aspect of
the intestinal lumen using a high frequency desiccator
(Aaron 900; Bovie Aaron Medical, St. Petersburg, FL,
USA) to carefully expose the opposing mucosa for micro-
circulation examination [17]. Nearby intestinal muscle
and Peyer’s patch were also identified for microcircula-
tion examination. The rats were observed for a 15-min-
ute stabilization period.
Grouping and protocol
The 30 rats were divided into the following three groups:
1, Sham OP; 2, LPS; and 3, LPS + Enoxaparin. After the
stabilization period, the time was set to 0 minutes. In the
LPS and LPS + Enoxaparin groups, a one-minute bolus
injection of 15 mg/kg LPS (Escherichia coli, O127:B8;
Sigma-Aldrich Co., St. Louis, MO, USA) in 3 ml/kg 0.9%
saline was given intravenously to induced endotoxemia
[17], then a one-minute bolus injection of 400 IU/kg enox-
aparin sodium in 2 ml/kg 5% dextrose was given in the
LPS + Enoxaparin group. In the Sham OP and LPS
groups, 2 ml/kg 5% dextrose was administered intrave-
nously. At 240 minutes, blood samples were obtained
from the right common carotid artery catheter for labora-
tory analysis. Euthanasia was performed by exsanguination
cardiac arrest under anesthesia.
Microcirculation examination
A full-field laser perfusion imager (MoorFLPI, Moor
Instruments Ltd., Devon, UK) was used to continuously
quantitate the microcirculatory blood flow intensity
[15,18]. This imager uses laser speckle contrast imaging,
which exploits the random speckle pattern that is gener-
ated when tissue is illuminated by laser light. The ran-
dom speckle pattern changes when blood cells move
within the region of interest (ROI). When there is a high
level of movement (fast flow), the changing pattern
becomes more blurred, and the contrast in that region
reduces accordingly. Therefore, low contrast is related to
high flow and high contrast to low flow. The contrast
image is processed to produce a 16-color coded image
that correlates with blood flow in the tissue such as blue
is defined as low flow and red as high flow. The microcir-
culatory blood flow intensity of each ROI was recorded as
Flux with perfusion unit (PU), which is related to the
product of average speed and concentration of moving
red blood cells in the tissue sample volume. The images
were recorded and analyzed in real time by the
MoorFLPI software version 3.0 (Moor Instruments Ltd.).
Three separate ROIs were established on mucosa, mus-
cle, and Peyer’s patch. The microcirculatory blood flow
intensities among the three groups were compared at the
following time points: 0, 60, 120, 180, and 240 minutes.
At 240 minutes, the SDF video microscope (MicroScan,
Microvision Medical, Amsterdam, The Netherlands) was
used to investigate total small vessel (less than 20 μm)
density, blood flow classification of each small vessel,
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perfused small vessel density, microvascular flow index
(MFI), and heterogeneity index (HI) [19]. This SDF ima-
ging device illuminates the tissues with polarized green
light and measures the reflected light from the tissue sur-
face. Both superficial capillaries and venules can be visua-
lized because the scattered green light is absorbed by the
hemoglobin of the red blood cells contained in these ves-
sels. At each time point, three continuous image
sequences (10 seconds) were digitally stored for each mea-
sured site and data of the three images were averaged for
statistics. The images were analyzed using automated ana-
lysis software (AVA 3.0, Academic Medical Center, Uni-
versity of Amsterdam, Amsterdam, The Netherlands).
Total small vessel density was automatically calculated by
the software. A semi-quantitative method was used to
classify the blood flow of each small vessel as follows: (0)
absent (no flow or filled with microthrombosis), (1) inter-
mittent flow (absence of flow for at least 50% of the time),
(2) sluggish flow, and (3) continuous flow [19]. Small ves-
sels with blood flow classified as (2) and (3) were consid-
ered as perfused small vessels, and the perfused small
vessel density was automatically calculated. To calculate
MFI score, the image was divided into four quadrants and
the same ordinal scale (0 to 3) was used to assess blood
flow in each quadrant. The MFI score represents the aver-
aged values of the four quadrants. The HI was calculated
as the highest MFI minus the lowest MFI divided by the
mean MFI across the three images of each measured site
at a certain time point [19]. The analyses were done by a
single investigator who was blinded to grouping.
Statistical analysis
Data were expressed as mean (standard deviation) and
analyzed with statistical software (SPSS 19; IBM SPSS,
Chicago, IL, USA). The study was powered (n = 10 rats
per group) to detect a 20% difference in microcircula-
tory blood flow intensity in intestinal mucosa among
the three groups at 240 minutes, with an alpha level of
0.017 (two-tailed) and a beta level of 0.2 (80% power),
assuming a control intensity of 1,200 ± 160 PU. Hemo-
dynamic, body temperature, and microcirculatory blood
flow intensity were analyzed with repeated measurement
analysis of variance followed by Tukey or Dunnett’s T3
multiple comparison tests. Total small vessel density,
perfused small vessel density, proportion of perfused
small vessels and HI were analyzed with one-way analy-
sis of variance followed by post hoc analysis with Tukey
or Dunnett’s T3 test. Data of MFI were expressed as
median (interquartile range) and analyzed with the
Kruskal-Wallis test, followed by post hoc Mann-Whit-
ney analysis with adjustment for multiple comparisons.
The error bars in all figures represent the 95% confi-
dence intervals of the mean values. A P value < 0.05
was considered to indicate a significant result.
Results
Enoxaparin prevented reduction in mean arterial pressure
Enoxaparin inhibited LPS-induced reduction in mean
arterial pressure (Figure 1A). At 240 minutes, the mean
arterial pressure was higher in the LPS + Enoxaparin
group than in the LPS group (93 ± 9 versus 64 ± 16 mm
Hg, P < 0.001). Neither heart rate nor body temperature
was significantly different between the LPS group and the
LPS + Enoxaparin group (Figure 1B and 1C).
Enoxaparin inhibited LPS-induced reduction in
microcirculatory blood flow intensity
Examples of the images of microcirculatory blood flow
intensity, as obtained by the full-field laser perfusion
imager, are shown in Figure 2. Enoxaparin inhibited the
LPS-induced reduction in microcirculatory blood flow
intensity (Figure 3). At 240 minutes, the microcircula-
tory blood flow intensity was higher in the LPS + Enox-
aparin group than in the LPS group as follows: mucosa
(1,085 ± 215 versus 617 ± 214 PU, P < 0.001); muscle
(760 ± 202 versus 416 ± 223 PU, P = 0.001); and Peyer’s
patch (1,116 ± 245 versus 570 ± 280 PU, P < 0.001).
Enoxaparin inhibited LPS-induced reduction in perfused
small vessel density and increase in heterogeneity in
microcirculation
Examples of the images of intestinal microvasculature, as
obtained by the SDF video microscope at 240 minutes,
are shown in Figure 4 and Additional file 1, 2, 3, 4, 5 and
6. The total and perfused small vessel density in the LPS
group decreased during the experiment (Figure 5), but
the difference of total small vessel density in intestinal
muscle was not significantly different between the Sham
OP group and LPS group. Enoxaparin greatly inhibited
the LPS-induced decrease in perfused small vessel density
at 240 minutes. The blood flow of many small vessels in
the LPS group was absent due to microthrombosis for-
mation. The HIs were higher in the LPS group than in
the LPS + Enoxaparin group. The microvascular flow
indexes were higher in the LPS + Enoxaparin group than
in the LPS group (Table 1).
Discussion
This study shows that enoxaparin can prevent intestinal
microcirculatory dysfunction in endotoxemic rats. The
evidence is that the microcirculatory blood flow inten-
sity, perfused small vessel density and microvascular
flow index were higher in the LPS + Enoxaparin group
than in the LPS group. We also found that the blood
flow of many small vessels in the LPS group was absent
due to microthrombosis formation and that the HIs
were higher in the LPS group than in the LPS + Enoxa-
parin group. These findings indicate that enoxaparin can
reduce microvascular thrombosis.
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Figure 1 Hemodynamic data and body temperature. (A) Mean arterial pressure (MAP). (B) Heart rate (HR). (C) Body temperatures (BT). Circle:
Sham OP group; square: LPS group; diamond: LPS + Enoxaparin group, n = 10 in each group. *P < 0.05 compared with the Sham OP group; †P
< 0.05 compared with the LPS + Enoxaparin group. LPS, lipopolysaccharide.
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Maintaining adequate and homogeneous perfused
small vessel density is very important to avoid tissue
hypoperfusion [20]. There are two important pieces of
evidence to support the finding that enoxaparin can
inhibit the LPS-induced reduction in perfused small ves-
sel density. First, the small vessels should be patent for
perfusion. During severe sepsis and septic shock, micro-
vascular thrombosis can obstruct the flow in small ves-
sels and prevent oxygen from reaching the surrounding
tissues. Moreover, microvascular thrombosis can direct
the microcirculatory blood flow to those small vessels
remaining patent and this will lead to microcirculatory
shunting [21]. The reduction in microvascular thrombo-
sis and lower HI in the LPS + Enoxaparin group support
the conclusion that enoxaparin can maintain adequate
and homogeneous perfused small vessels density.
Second, small vessels require adequate arterial pres-
sure for sufficient perfusion. During severe sepsis and
septic shock, LPS may activate overt immune and
inflammatory responses, which can result in hypovole-
mia by capillary leakage of fluid and protein [22], cause
pathological vasodilation by nitric oxide production [23],
Figure 2 Images of microcirculatory blood flow intensity of terminal ileum obtained by the full-field laser perfusion imager. Images for
each group are as follows: (A) Sham OP group, (B) LPS group and (C) LPS + Enoxaparin group. LPS, lipopolysaccharide.
Yeh et al. Critical Care 2012, 16:R59
http://ccforum.com/content/16/2/R59
Page 5 of 10
Figure 3 Comparison of microcirculatory blood flow intensity of the terminal ileum. Circle: Sham OP group; square: LPS group; diamond:
LPS + Enoxaparin group, n = 10 in each group. *P < 0.05 compared with the Sham OP group; †P < 0.05 compared with the LPS + Enoxaparin
group. LPS, lipopolysaccharide.
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and decrease cardiac contractility by myocardial sup-
pression [24]. These derangements can lead to hypoten-
sion. The finding that mean arterial pressure remained
normal in the LPS + Enoxaparin group indicates that
enoxaparin can maintain adequate perfused small vessel
density. The mechanism for this protective effect may
be related to the anti-inflammatory effect of low mole-
cular weight heparin, which was revealed in previous
studies [25-27]. Iba and colleagues [25] demonstrated
that not only the improvement of coagulation disorder
but also the regulation of circulating levels of pro-
inflammatory cytokines may play a role in the mechan-
ism to preserve the organ dysfunction in LPS-challenged
rats. Moreover, they also found that enoxaparin protects
against endothelial damage by preventing leukocyte
adhesion in endotoxemic rats [16]. Many observations
support the finding that endothelial activation and dys-
function play a pivotal role in microcirculatory dysfunc-
tion during sepsis [28-30]. This may be one of the
mechanisms of microcirculatory dysfunction that enoxa-
parin can prevent.
Compared with a lower LPS concentration rat model,
the rats in this study experienced a normotensive endo-
toxemia (0 to 180 minutes) to shock status (240 min-
utes). In Figure 3, we can notice that microcirculatory
dysfunction deteriorated early at 60 minutes. Consistent
with this finding, previous studies have demonstrated
that microcirculatory flow alterations can occur in the
absence of global hemodynamic derangements [31,32].
The advantage of our rat model is quick investigation of
Figure 4 Images of microcirculation in terminal ileum obtained by the sidestream dark field (SDF) video microscope at 240 minutes.
Images for each group are as follows: (A) Sham OP group, (B) LPS group and (C) LPS + Enoxaparin group. There are small vessels
microthrombosis (black arrow), and some small vessels are absent (white arrow) in the LPS group. LPS, lipopolysaccharide.
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microcirculatory dysfunction within four hours. For
exclusive focus on microcirculation for a longer period,
a lower LPS concentration rat model is suggested [33].
This rat model has several limitations. First, as in other
endotoxemic rat models, early treatment does not reflect
the clinical situation [34]. The effect of post-LPS treat-
ment requires further investigation. Second, two rats in
the LPS + Enoxaparin group had minor bleeding from
surgical wounds in the intestine which were quickly
stopped after electrocoagulation using a high frequency
desiccator. Although previous study revealed that enoxa-
parin attenuates endothelial damage with less bleeding
compared with unfractionated heparin [16], the bleeding
complications should be followed up in other conditions
such as late stage of sepsis or prolonged use of enoxa-
parin. Third, there was still a little small vessel micro-
thrombosis in the LPS + Enoxaparin group. This might
be due to an incomplete effect of enoxaparin or throm-
bin inhibitors induced clotting [35].
Conclusions
In summary, this study shows that enoxaparin can prevent
intestinal microcirculatory dysfunction in endotoxemic
Figure 5 Comparison of total and perfused small vessel density and heterogeneity index of terminal ileum at 240 minutes. 1: Sham OP
group, 2: LPS group and 3: LPS + Enoxaparin group. *P < 0.05 compared with the Sham OP group; †P < 0.05 compared with the LPS +
Enoxaparin group. HI, heterogeneity index; LPS, lipopolysaccharide; PSVD, perfused small vessel density; TSVD, total small vessel density.
Table 1 Microvascular flow index
Group Mucosa Muscle Peyer’s patch
Sham OP 2.9 (2.7-3.0) 2.8 (2.8-3.0) 2.9 (2.8-3.0)
LPS 1.1 (0.5-1.7) *† 0.6 (0.5-1.5)*† 1.1 (0.9-1.6)*†
LPS + Enoxaparin 2.9 (2.7-3.0) 3.0 (2.1-3.0) 2.5 (1.4-3.0)
Data are presented as median (interquartile range). *P < 0.05 compared with
the Sham OP group; †P < 0.05 compared with the LPS + Enoxaparin group.
LPS, lipopolysaccharide.
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rats. Enoxaparin inhibits the LPS-induced reduction in
perfused small vessel density and increase in heterogeneity
of microcirculation by preventing microvascular thrombo-
sis formation and maintaining normal mean arterial pres-
sure. Besides preventing microvascular thrombosis,
enoxaparin may modulate inflammation and reduce
endothelial dysfunction. Combining these effects, further
studies may be warranted to establish the value and role of
enoxaparin in early resuscitation of microcirculatory dys-
function in patients with severe sepsis and septic shock.
Key messages
• Enoxaparin can prevent intestinal microcirculatory
dysfunction in endotoxemic rats.
• Enoxaparin inhibits LPS-induced reduction in per-
fused small vessel density and increase in heteroge-
neity of microcirculation by preventing
microvascular thrombosis formation and maintaining
normal mean arterial pressure.
Additional material
Additional file 1: Microcirculation video of intestinal mucosa of
Sham OP group.
Additional file 2: Microcirculation video of intestinal muscle of
Sham OP group.
Additional file 3: Microcirculation video of intestinal mucosa of LPS
group.
Additional file 4: Microcirculation video of intestinal muscle of LPS
group.
Additional file 5: Microcirculation video of intestinal mucosa of LPS
+ Enoxaparin group.
Additional file 6: Microcirculation video of intestinal muscle of LPS
+ Enoxaparin group.
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